These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14973420)

  • 1. Non-oncologic applications of radiolabeled peptides in nuclear medicine.
    Knight LC
    Q J Nucl Med; 2003 Dec; 47(4):279-91. PubMed ID: 14973420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide radiopharmaceuticals for diagnosis and therapy.
    Signore A; Annovazzi A; Chianelli M; Corsetti F; Van de Wiele C; Watherhouse RN
    Eur J Nucl Med; 2001 Oct; 28(10):1555-65. PubMed ID: 11685500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-based radiopharmaceuticals: future tools for diagnostic imaging of cancers and other diseases.
    Okarvi SM
    Med Res Rev; 2004 May; 24(3):357-97. PubMed ID: 14994368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of radionuclide tracer imaging of thrombi and atheroma.
    Cerqueira MD
    Semin Nucl Med; 1999 Oct; 29(4):339-51. PubMed ID: 10534236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabeled peptides in diagnosis and therapy.
    Weiner RE; Thakur ML
    Semin Nucl Med; 2001 Oct; 31(4):296-311. PubMed ID: 11710772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiopharmaceuticals for scintigraphic imaging of infection and inflammation.
    Boerman OC; Dams ET; Oyen WJ; Corstens FH; Storm G
    Inflamm Res; 2001 Feb; 50(2):55-64. PubMed ID: 11289655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic peptides come of age.
    Miller L
    J Nucl Med; 1993 Nov; 34(11):15N, 18N, 27N-30N. PubMed ID: 7901351
    [No Abstract]   [Full Text] [Related]  

  • 8. Novel technetium-99m-labeled platelet GPIIb/IIIa receptor antagonists as potential imaging agents for venous and arterial thrombosis.
    Mousa SA; Bozarth JM; Edwards S; Carroll T; Barrett J
    Coron Artery Dis; 1998; 9(2-3):131-41. PubMed ID: 9647415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for the use of radiolabelled peptides in diagnosis and therapy.
    Koopmans KP; Glaudemans AW
    Eur J Nucl Med Mol Imaging; 2012 Feb; 39 Suppl 1():S4-10. PubMed ID: 22388630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Overview of Bioactive Peptides for in vivo Imaging and Therapy in Human Diseases.
    Tornesello AL; Tornesello ML; Buonaguro FM
    Mini Rev Med Chem; 2017; 17(9):758-770. PubMed ID: 28117023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases.
    Sosabowsky J; Melendez-Alafort L; Mather S
    Q J Nucl Med; 2003 Dec; 47(4):223-37. PubMed ID: 14973415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiopharmaceuticals to image infection and inflammation.
    Boerman OC; Rennen H; Oyen WJ; Corstens FH
    Semin Nucl Med; 2001 Oct; 31(4):286-95. PubMed ID: 11710771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent developments in 99Tcm-labelled peptide-based radiopharmaceuticals: an overview.
    Okarvi SM
    Nucl Med Commun; 1999 Dec; 20(12):1093-112. PubMed ID: 10664991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabeled chemotactic cytokines: new agents for scintigraphic imaging of infection and inflammation.
    van Eerd JE; Boerman OC; Corstens FH; Oyen WJ
    Q J Nucl Med; 2003 Dec; 47(4):246-55. PubMed ID: 14973417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scintigraphic detection of infection and inflammation: new developments with special emphasis on receptor interaction.
    van der Laken CJ; Boerman OC; Oyen WJ; van de Ven MT; van der Meer JW; Corstens FH
    Eur J Nucl Med; 1998 May; 25(5):535-46. PubMed ID: 9575251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiopharmaceuticals for the study of inflammatory processes: a review.
    Chianelli M; Mather SJ; Martin-Comin J; Signore A
    Nucl Med Commun; 1997 May; 18(5):437-55. PubMed ID: 9194086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 99mTc-antimicrobial peptides: promising candidates for infection imaging.
    Lupetti A; Pauwels EK; Nibbering PH; Welling MM
    Q J Nucl Med; 2003 Dec; 47(4):238-45. PubMed ID: 14973416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Scintigraphic diagnosis of inflammation and infection].
    Todorović-Tirnanić M; Obradović V; Artiko V; Sobic-Saranović D; Davidović B; Pavlović S; Bosnjaković V
    Glas Srp Akad Nauka Med; 2005; (48):55-83. PubMed ID: 16405231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated platelets.
    Bednar RA; Gaul SL; Hamill TG; Egbertson MS; Shafer JA; Hartman GD; Gould RJ; Bednar B
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1317-26. PubMed ID: 9618439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Atherosclerosis: imaging techniques and the evolving role of nuclear medicine.
    Vallabhajosula S; Fuster V
    J Nucl Med; 1997 Nov; 38(11):1788-96. PubMed ID: 9374357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.